
RUA Life Sciences plc – LSE:RUA.L
RUA Life Sciences stock price today
RUA Life Sciences stock price monthly change
RUA Life Sciences stock price quarterly change
RUA Life Sciences stock price yearly change
RUA Life Sciences key metrics
Market Cap | 6.53M |
Enterprise value | 8.90M |
P/E | N/A |
EV/Sales | N/A |
EV/EBITDA | N/A |
Price/Sales | N/A |
Price/Book | 0.01 |
PEG ratio | N/A |
EPS | -0.15 |
Revenue | 3.43M |
EBITDA | -3.67M |
Income | -3.39M |
Revenue Q/Q | N/A |
Revenue Y/Y | N/A |
Profit margin | 0% |
Oper. margin | 0% |
Gross margin | 0% |
EBIT margin | 0% |
EBITDA margin | -107.21% |
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeRUA Life Sciences stock price history
RUA Life Sciences stock forecast
RUA Life Sciences financial statements
Dec 2021 | 458.5K | -378K | -82.44% |
---|---|---|---|
Sep 2022 | 1.10M | -1.14M | -103.53% |
Mar 2023 | 1.07M | -860K | -80% |
Sep 2023 | 794K | -1.01M | -127.2% |
2026 | 4.27M | 435K | 10.18% |
---|
Analysts Price target
Financials & Ratios estimates
Jun 2022 | 6597000 | 1.11M | 16.84% |
---|---|---|---|
Sep 2022 | 6597000 | 1.11M | 16.84% |
Dec 2022 | 5663000 | 980K | 17.31% |
Sep 2023 | 4754000 | 1.02M | 21.46% |
Sep 2021 | -1.10M | -397K | -31K |
---|---|---|---|
Sep 2022 | -470K | -94K | 110K |
Mar 2023 | -704K | -355K | 22K |
Sep 2023 | -904K | -42K | -30K |
RUA Life Sciences alternative data
Aug 2023 | 38 |
---|---|
Sep 2023 | 38 |
Oct 2023 | 48 |
Nov 2023 | 48 |
Dec 2023 | 48 |
Jan 2024 | 48 |
Feb 2024 | 48 |
Mar 2024 | 48 |
Apr 2024 | 48 |
May 2024 | 48 |
Jun 2024 | 48 |
Jul 2024 | 48 |
RUA Life Sciences other data
Insider | Compensation |
---|---|
Mr. William Donald Brown (1964) Executive Chairman & Fin. Director | $182,880 |
Dr. Caroline Stretton (1971) Group MD & Director | $108,680 |
Mr. John McKenna (1953) Director of Clinical Marketing & Executive Director | $52,250 |
-
What's the price of RUA Life Sciences stock today?
One share of RUA Life Sciences stock can currently be purchased for approximately $75.
-
When is RUA Life Sciences's next earnings date?
Unfortunately, RUA Life Sciences's (RUA.L) next earnings date is currently unknown.
-
Does RUA Life Sciences pay dividends?
No, RUA Life Sciences does not pay dividends.
-
How much money does RUA Life Sciences make?
RUA Life Sciences has a market capitalization of 6.53M and it's past years’ income statements indicate that its last revenue has increased compared to the previous period by 34.83% to 2.19M US dollars.
-
What is RUA Life Sciences's stock symbol?
RUA Life Sciences plc is traded on the LSE under the ticker symbol "RUA.L".
-
What is RUA Life Sciences's primary industry?
Company operates in the Healthcare sector and Medical - Devices industry.
-
How do i buy shares of RUA Life Sciences?
Shares of RUA Life Sciences can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are RUA Life Sciences's key executives?
RUA Life Sciences's management team includes the following people:
- Mr. William Donald Brown Executive Chairman & Fin. Director(age: 61, pay: $182,880)
- Dr. Caroline Stretton Group MD & Director(age: 54, pay: $108,680)
- Mr. John McKenna Director of Clinical Marketing & Executive Director(age: 72, pay: $52,250)
-
How many employees does RUA Life Sciences have?
As Jul 2024, RUA Life Sciences employs 48 workers.
-
When RUA Life Sciences went public?
RUA Life Sciences plc is publicly traded company for more then 28 years since IPO on 26 Feb 1997.
-
What is RUA Life Sciences's official website?
The official website for RUA Life Sciences is rualifesciences.com.
-
How can i contact RUA Life Sciences?
RUA Life Sciences can be reached via phone at +44 1294 317073.
RUA Life Sciences company profile:

RUA Life Sciences plc
rualifesciences.comLSE
40
Medical - Devices
Healthcare
RUA Life Sciences plc, together with its subsidiaries, provides polymers, services, and products to the medical device industry in Europe, the United States, and internationally. The company operates as a contract developer and manufacturer of medical devices; and licensor of Elast-Eon and ECSil implantable co-polymers that are used in cardiology and urological applications, including pacing leads, cardiac cannulae, and stent devices, as well as reaction injection molding technology for use in high-precision medical device components. It also develops bore polymer sealed grafts and soft tissue patches; and tri leaflet polymeric heart valves. The company was formerly known as AorTech International plc and changed its name to RUA Life Sciences plc in June 2020. RUA Life Sciences plc was incorporated in 1996 and is headquartered in Irvine, the United Kingdom.
Irvine, KA11 5AN
:
ISIN: GB0033360586
CUSIP: G0402P119